Clinical results of radionuclide therapy
✍
Jolanta Kunikowska; Leszek Królicki; Alicja Hubalewska-Dydejczyk; Renata Mikołaj
📂
Article
📅
2011
🏛
Springer
🌐
English
⚖ 487 KB
## Purpose Peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues is a treatment option for patients with disseminated neuroendocrine tumours (NET). A combination treatment using the high-energy ^90^Y beta emitter for larger lesions and the lower energy ^177^Lu for